|131.29||+0.54 / +0.42%|
As of May 22
|132.36||+1.07 / +0.81%|
The 25 analysts offering 12-month price forecasts for Bayer have a median target of 125.70, with a high estimate of 157.59 and a low estimate of 94.54. The median estimate represents a -4.26% decrease from the last price of 131.29.
The current consensus among 26 polled investment analysts is to Buy stock in Bayer. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.